ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1921

Relation of Sensitization and Conditioned Pain Modulation to Post-Knee Replacement Pain

Tuhina Neogi1, Na Wang2, Cora E. Lewis3, Michael C. Nevitt4 and Laura Frey-Law5, 1Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3University of Alabama Birmingham, Birmingham, AL, 4Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 5University of Iowa, Iowa City, IA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Joint arthroplasty and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: 4M103 ACR Abstract: Pain Mechanisms–Basic & Clinical Science (1917–1922)

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Alterations in pain processing, such as pain sensitization and inadequate conditioned pain modulation (CPM), may contribute to the observed pain persistence post-knee replacement (KR) in 20-30% of patients, but studies to date have been conflicting. Further, many studies have been small and comprised only subjects who experienced post-KR pain improvement. It is therefore not known if altered pain processing is present in those with persistent post-KR pain. We undertook a comprehensive evaluation of pain sensitization and CPM in relation to post-KR pain.

Methods: The Multicenter Osteoarthritis (MOST) Study is a NIH-funded longitudinal cohort of persons with or at high risk of knee OA. We evaluated subjects prior to KR and 12-18 months post-KR with a standardized somatosensory evaluation of mechanical pressure pain thresholds (PPT) at the wrist and patellae, temporal summation (TS) at the wrist, and WOMAC pain questionnaires. CPM was assessed post-KR. PPT was assessed with an algometer (1cm2 tip, 0.5 Kg/sec) as the point at which pressure first changed to slight pain; 3 trials at each anatomic site were averaged. Lower PPT indicates more pain sensitivity, reflecting peripheral sensitization at a site of disease and central sensitization at a site without disease. Temporal summation, indicating central sensitization, was defined by increased pain during repeated mechanical stimulation (1 Hz x 30-sec) with a 60g monofilament. CPM was assessed using the forearm ischemia test. Inadequate CPM was defined as a ratio of <1, indicating lack of increase in post-conditioning stimulus PPT. We evaluated the relation of pre- and post-KR PPT and TS, and of post-KR CPM to post-KR WOMAC pain and to a minimal clinically important difference (MCID) in WOMAC pain, adjusting for potential confounders.

Results: There were 171 subjects in our study who were seen before and after their KR (mean age 69, 62% female, mean BMI 31). Pre-KR PPT and pre-KR TS were not associated with post-KR WOMAC pain (Table). Post-KR TS and inadequate CPM were significantly associated with a worse WOMAC pain score post-KR, and nonsignficantly with lower likelihood of achieving the MCID.

Conclusion: Pre-KR PPT and TS were not associated with post-KR pain levels or pain improvement. Thus, while PPT and TS are associated with pain severity overall in knee OA subjects, they do not adequately predict pain response to KR. Post-KR presence of TS and inadequate CPM were associated with worse pain post-KR, suggesting a role for central altered pain processing in pain persistence post-KR, and provide support for pain phenotyping to guide mechanism-based treatment approaches.

Post-KR WOMAC Pain

Minimal Clinically Important Difference (MCID) in Post-KR WOMAC Pain **

Mean difference in WOMAC Pain*

(95% CI)

P-value

OR (95% CI)

P-value

Pre-KR Measures:

Pre-KR TS

0.11 (-0.31, 0.54)

0.6

0.93 (0.70, 1.24)

0.6

Pre-KR PPT at wrist

-0.19 (-0.59, 0.20)

0.3

1.11 (0.84, 1.47)

0.5

Pre-KR PPT at patella

-0.07 (-0.32, 0.19)

0.6

1.02 (0.84, 1.23)

0.9

Post-KR Measures:

Post-KR TS

0.82 (0.19, 1.45)

0.01

0.73 (0.44, 1.21)

0.2

Post-KR PPT wrist

-0.21 (-0.63, 0.21)

0.3

0.99 (0.75, 1.31)

0.9

Post-KR PPT patella

-0.15 (-0.45, 0.15)

0.3

1.02 (0.82, 1.26)

0.9

Inadequate CPM (<1)

1.47 (0.26, 2.68)

0.02

0.78 (0.56, 3.00)

0.6

*Mean differences refers to an increase (positive value, indicating worsened pain) or decrease (negative value indicating pain improvement) in WOMAC pain post-KR relative to pre-KR value per unit increase in continuous variables (TS, PPT) or for those with vs. without that feature for dichotomous variables (inadequate CPM)

**Defined as an improvement of at least 5.6/20 (Escobar, et al. 2007)

Analyses were adjusted for age, sex, BMI, depressive symptoms, pain catastrophizing, clinic site, time of clinic assessments relative to KR date


Disclosure: T. Neogi, None; N. Wang, None; C. E. Lewis, None; M. C. Nevitt, None; L. Frey-Law, None.

To cite this abstract in AMA style:

Neogi T, Wang N, Lewis CE, Nevitt MC, Frey-Law L. Relation of Sensitization and Conditioned Pain Modulation to Post-Knee Replacement Pain [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/relation-of-sensitization-and-conditioned-pain-modulation-to-post-knee-replacement-pain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relation-of-sensitization-and-conditioned-pain-modulation-to-post-knee-replacement-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology